Biogen Stock Declines 21.4 percent in 3 Months How to Play the Stock
SAGE Stock | USD 5.55 0.02 0.36% |
About 52% of Sage Therapeutic's shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Sage Therapeutic suggests that some traders are interested. The current market sentiment, together with Sage Therapeutic's historical and current headlines, can help investors time the market. In addition, many technical investors use Sage Therapeutic stock news signals to limit their universe of possible portfolio assets.
Sage |
Though there is uncertainty about Biogens sales and profits improving significantly, investors can hold the stock given the potential of its new drugs.
Read at zacks.com
Sage Therapeutic Current Investor Sentiment
Panic Vs Confidence
52
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Sage Therapeutic's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Sage Therapeutic.
News SentimentBullish | Hype SentimentBearish | Insider SentimentAcquiring |
Sage Therapeutic Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Sage Therapeutic can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Sage Therapeutic Fundamental Analysis
We analyze Sage Therapeutic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sage Therapeutic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sage Therapeutic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Debt To Equity
Debt To Equity Comparative Analysis
Sage Therapeutic is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Sage Therapeutic Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sage Therapeutic stock to make a market-neutral strategy. Peer analysis of Sage Therapeutic could also be used in its relative valuation, which is a method of valuing Sage Therapeutic by comparing valuation metrics with similar companies.
Peers
Sage Therapeutic Related Equities
TERN | Terns Pharmaceuticals | 5.17 | ||||
BDTX | Black Diamond | 2.09 | ||||
BPMC | Blueprint Medicines | 0.87 | ||||
INCY | Incyte | 0.36 | ||||
ALNY | Alnylam Pharmaceuticals | 0.15 | ||||
KRYS | Krystal Biotech | 0.31 | ||||
NUVL | Nuvalent | 1.01 | ||||
APLS | Apellis Pharmaceuticals | 1.09 | ||||
AKRO | Akero Therapeutics | 1.54 | ||||
MDGL | Madrigal Pharmaceuticals | 1.78 | ||||
DAWN | Day One | 1.86 | ||||
PLRX | Pliant Therapeutics | 2.89 | ||||
IMCR | Immunocore Holdings | 3.14 | ||||
DMAC | DiaMedica Therapeutics | 3.19 | ||||
STOK | Stoke Therapeutics | 3.63 | ||||
RLAY | Relay Therapeutics | 5.74 | ||||
ARVN | Arvinas | 6.47 | ||||
AMLX | Amylyx Pharmaceuticals | 7.58 | ||||
VTYX | Ventyx Biosciences | 7.64 |
Complementary Tools for Sage Stock analysis
When running Sage Therapeutic's price analysis, check to measure Sage Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sage Therapeutic is operating at the current time. Most of Sage Therapeutic's value examination focuses on studying past and present price action to predict the probability of Sage Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sage Therapeutic's price. Additionally, you may evaluate how the addition of Sage Therapeutic to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
CEOs Directory Screen CEOs from public companies around the world | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |